Noritren (Nortriptyline Hydrochloride)

Nortriptyline Hydrochloride, the active ingredient in Noritren, is a tricyclic antidepressant presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients. GNH USA supplies Noritren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nortriptyline Hydrochloride is a tricyclic antidepressant used primarily in the management of depressive disorders. - Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients.

Noritren may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry mouth: reduced salivary secretion leading to discomfort. - Constipation: slowed gastrointestinal motility. - Drowsiness: increased sedation, especially at treatment initiation. - Weight gain: gradual increase in body weight during therapy.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Seizures: risk of convulsive episodes, particularly in predisposed individuals. - Severe hypotension: marked drop in blood pressure that may cause fainting.

Before prescribing Noritren, clinicians should consider several safety measures. - Assess cardiac history: obtain baseline ECG and monitor for conduction abnormalities. - Monitor blood pressure: watch for orthostatic hypotension, especially during dose escalation. - Avoid abrupt discontinuation: taper the dose under medical supervision to prevent withdrawal symptoms. - Use caution in elderly: increased sensitivity to anticholinergic and sedative effects. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Nortriptyline Hydrochloride can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: heightened serotonin toxicity. - Linezolid or tramadol: potential for additive serotonergic effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance orthostatic hypotension. - CNS depressants (e.g., benzodiazepines, alcohol): increased sedation. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise nortriptyline plasma levels.